Overview

A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

Status:
Completed
Trial end date:
2016-12-29
Target enrollment:
Participant gender:
Summary
An Open-Label, Randomized, Single-dose, 2x2 Crossover Study to Compare the Pharmacokinetics of BRI-1501 Tablet and Coadministration of Lafutidine and Irsogladine maleate as Individual Tablets in Healthy Adult Volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Treatments:
Irsogladine
Lafutidine
Maleic acid